ABIGAIL SHAW: Open Payments
NPI 1770213670 · VIENNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 68 payments from 16 companies in 2025. Trend: 2023 $2,454 · 2024 $2,310 · 2025 $1,538
Food & beverage: $1,438Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $430 |
| LEO Pharma Inc. | 14 | $192 |
| Botanix SB Inc | 5 | $167 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| UCB, Inc. | 4 | $94 |
| Amgen Inc. | 3 | $85 |
| ABBVIE INC. | 4 | $78 |
| Incyte Corporation | 3 | $72 |
| Lilly USA, LLC | 3 | $61 |
Products named: TREMFYA, SOFDRA, ADBRY, Winlevi, Bimzelx, OTEZLA, OPZELURA, SKYRIZI.
Industry payments across VA — which companies pay providers there.
